Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial

Effect of Anagliptin versus Sitagliptin on Inflammatory Markers: Sub-Analysis from the REASON Trial

Hiroki Teragawa,1 Takeshi Morimoto,2 Yuichi Fujii,1 Tomohiro Ueda,1 Mio Sakuma,2 Michio Shimabukuro,3 Osamu Arasaki,4 Koichi Node,5 Takashi Nomiyama,6 Shinichiro Ueda7 1Department of Cardiovascular Medicine, JR Hiroshima Hospital, Hiroshima, Japan; 2Department of Clinical Epidemiology, Hyogo College...

Full description

Bibliographic Details
Main Authors: Teragawa H, Morimoto T, Fujii Y, Ueda T, Sakuma M, Shimabukuro M, Arasaki O, Node K, Nomiyama T, Ueda S
Format: Article
Language:English
Published: Dove Medical Press 2020-12-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
c-reactive protein
dipeptidylpeptidase-4
dpp-4 inhibitor
inflammation
interleukin-6
white blood cell
Online Access:https://www.dovepress.com/effect-of-anagliptin-versus-sitagliptin-on-inflammatory-markers-sub-an-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/effect-of-anagliptin-versus-sitagliptin-on-inflammatory-markers-sub-an-peer-reviewed-article-DMSO

Similar Items